Table: Kobayashi Pharmaceutical - 9-MTH group results

Kobayashi Pharmaceutical

01/11/2022 06:00

Nov 1 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Dec 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            114.28              107.66           162.00    
                 (+6.1 pct)          (+2.5 pct)       (+4.3 pct)  
  Operating         18.75               19.43            27.00    
                 (-3.5 pct)          (-0.5 pct)       (+3.6 pct)  
  Recurring         20.43               21.02            28.20    
                 (-2.8 pct)          (-0.1 pct)       (+0.7 pct)  
  Net               14.50               14.88            20.20    
                 (-2.6 pct)          (-2.5 pct)       (+2.5 pct)  
  EPS            187.52 yen          190.42 yen       259.85 yen  
  Ann Div                             83.00 yen        85.00 yen  
  -Q2 div         38.00 yen           37.00 yen                   
  -Q4 div                             46.00 yen        47.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T